MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide (PEP) Platform

Monday, August 5, 2024 1 min read

Key Takeaway: MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide (PEP) Platform

Full Press Release Details

MBX Biosciences Raises $63.5 Million in Series C Financing to Advance Precision Endocrine Peptide (PEP) Platform.